PDL BioPharma

Since its inception, PDL's mission has been to improve patients' lives by successfully developing innovative therapeutic and healthcare technologies.PDL BioPharma was founded in 1986 as Protein Design Labs, Inc., where it pioneered the humanization of monoclonal antibodies, leading to the discovery of a new generation of targeted treatments that have profoundly impacted patients with various cancers, multiple types of cancer, and other debilitating diseases. In 2006, the company changed its name to PDL BioPharma, Inc.